Picture of Evotec SE logo

EVT — Evotec SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Brief: Evotec Announces Nomination Of First Preclinical Development Candidate In Dermatology Collaboration With Almirall

May 4 (Reuters) - EVOTEC SE EVTG.DE:

ANNOUNCES NOMINATION OF FIRST PRECLINICAL DEVELOPMENT CANDIDATE IN DERMATOLOGY COLLABORATION WITH ALMIRALL

PROGRAM IS AIMED AT DEVELOPING NOVEL TREATMENTS FOR IMMUNE‑MEDIATED INFLAMMATORY SKIN DISEASES WITH HIGH UNMET MEDICAL NEED

Source text: ID:nEQTsfGfa

Further company coverage: EVTG.DE

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Evotec SE

See all news